MorphoSys Overview

  • Founded
  • 1992
Founded
  • Status
  • Public
  • Employees
  • 609
Employees
  • Stock Symbol
  • MOR
Stock Symbol
  • Investments
  • 8
  • Share Price
  • $80.51
  • (As of Friday Closing)

MorphoSys General Information

Description

MorphoSys AG is a biotechnology company that develops therapeutic antibodies. The company reports two business segments: partnered discovery and proprietary development. Its partnered discovery segment applies the research, development, and optimization of antibody-drug candidates in partnerships with pharmaceutical and biotechnology companies. MorphoSys' profits in this segment stem from successful programs via milestone payments and potential royalties on product sales. In its proprietary development segment, the company develops antibodies that concentrate on inflammatory and autoimmune diseases, as well as cancer and infectious diseases.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Stock Exchange
ETR
Primary Office
  • Semmelweisstrasse 7
  • 82152 Planegg
  • Germany
+49 089 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MorphoSys Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$80.51 $81.18 $73.67 - $144.73 $2.64B 32.8M 246K -$6.30

MorphoSys Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 1,902,875 2,905,240 4,122,981 2,705,354
Revenue 144,073 373,548 80,326 90,207
EBITDA (241,103) 39,884 (112,843) (66,545)
Net Income (204,540) 111,587 (115,319) (66,287)
Total Assets 1,934,171 2,041,146 556,097 616,293
Total Debt 375,906 391,378 47,685 82
Public Fundamental Data provided by Morningstar, Inc. disclaimer

MorphoSys Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MorphoSys‘s full profile, request access.

Request a free trial

MorphoSys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
MorphoSys AG is a biotechnology company that develops therapeutic antibodies. The company reports two business segments:
Biotechnology
Planegg, Germany
609 As of 2021
00000
000000000 00000

000 (000

um dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
0000 000000000
San Francisco, CA
000 As of 0000
00000
000000 - 000 00000

00000 00

lum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa q
0000 00000000
South San Francisco, CA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MorphoSys Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vir (Biotechnology) Formerly VC-backed San Francisco, CA 000 00000 000000 - 000 00000
00000 000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
0000000 Formerly VC-backed Saint-Herblain, France 000 00000 000000000 00000
0000000 Formerly VC-backed Waltham, MA 000 00000 000000 - 000 00000
00000000 000000 Corporation Hellerup, Denmark 000 00000 000000000 00000
You’re viewing 5 of 29 competitors. Get the full list »

MorphoSys Executive Team (26)

Name Title Board Seat Contact Info
Jean-Paul Kress MD Chief Executive Officer & Management Board Member
Jens Holstein Chief Financial Officer, Finance
Roland Wandeler Chief Operating Officer
Julia Neugebauer Director, Communications
Malte Peters MD Executive
You’re viewing 5 of 26 executive team members. Get the full list »

MorphoSys Board Members (10)

Name Representing Role Since
000000 0000000000 00.0 Self Board Member 000 0000
0000 000000 00.0 MorphoSys Chairman of Supervisory Board & Board Member 000 0000
0000000 0000000 MorphoSys Board Member 000 0000
00000 0000000 Self Board Member 000 0000
You’re viewing 4 of 10 board members. Get the full list »

MorphoSys Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MorphoSys Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore MorphoSys‘s full profile, request access.

Request a free trial

MorphoSys Investments & Acquisitions (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000000 0000 02-Jun-2021 000000000000000000 00.00 Biotechnology 0000-0000 00000 00
00000 19-Jul-2018 0000 00000 00.000 Other Services (B2C Non-Financial)
0000000 000000 07-May-2015 000000000000000000 000.00 Other Pharmaceuticals and Biotechnology 00000 0000000 00.0
0000000 000000 (00 17-Oct-2014 000000000000000000 Other Healthcare Technology Systems 0000 00000000
Lanthio Pharma 27-Nov-2012 Early Stage VC 00.000 Other Pharmaceuticals and Biotechnology 0000 00000000
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

MorphoSys Subsidiaries (1)

Company Name Industry Location Founded
0000000 000000 Other Pharmaceuticals and Biotechnology Groningen, Netherlands 0000
To view MorphoSys’s complete subsidiaries history, request access »

MorphoSys Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000 0000000 11-Jan-2006 000000000000000000 0000 Completed
  • 000000000
To view MorphoSys’s complete exits history, request access »